The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review

被引:55
作者
Arrais, RF
Dib, SA
机构
[1] Univ Fed Rio Grande do Norte, Dept Pediat, Children & Adolescent Endocrinol Unit, BR-59010180 Natal, RN, Brazil
[2] Univ Fed Sao Paulo, Div Endocrinol, BR-04039002 Sao Paulo, Brazil
关键词
diabetes; fertility; hyperandrogenism; menarche; menstrual dysfunction;
D O I
10.1093/humrep/dei353
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A high prevalence of menstrual cycle and fertility disturbances has long been associated with diabetes mellitus. However, rationalization of the intrinsic mechanisms of these alterations is controversial and even contradictory. This review considers (i) the relationship between diabetes mellitus, especially type 1 diabetes mellitus (T1DM), and the hypothalamus-pituitary-ovary (HPO) axis, (ii) the state of our knowledge concerning neuroendocrine control and its relationship with dopaminergic and opioid tonus, and (iii) the influence of the hypothalamus-pituitary-adrenal axis on ovarian function. Functional disturbances that occur as a consequence of diabetes are also discussed, but some T1DM-related diseases of autoimmune origin, such as oophoritis, are not further analysed. Although there are clear indications of a relationship between menstrual and fertility alterations and glycaemic control, in many instances the improvement of the latter is not sufficient to reverse such alterations. It appears that the oligoamenorrhoea and amenorrhoea associated with T1DM is mainly of hypothalamic origin (i.e. failure of the GnRH pulse generator) and may be reversible. The importance of the evaluation of the HPO axis in T1DM women with menstrual irregularities, even in the presence of adequate metabolic control, is emphasized.
引用
收藏
页码:327 / 337
页数:11
相关论文
共 88 条
  • [1] MENSTRUAL IRREGULARITIES ARE MORE COMMON IN ADOLESCENTS WITH TYPE-1 DIABETES - ASSOCIATION WITH POOR GLYCEMIC CONTROL AND WEIGHT-GAIN
    ADCOCK, CJ
    PERRY, LA
    LINDSELL, DRM
    TAYLOR, AM
    HOLLY, JMP
    JONES, J
    DUNGER, DB
    [J]. DIABETIC MEDICINE, 1994, 11 (05) : 465 - 470
  • [2] ANDERSEN AN, 1984, DAN MED BULL, V31, P413
  • [3] SEX-HORMONE-BINDING GLOBULIN
    ANDERSON, DC
    [J]. CLINICAL ENDOCRINOLOGY, 1974, 3 (01) : 69 - 96
  • [4] [Anonymous], WILLIAMS TXB ENDOCRI
  • [5] ALTERATIONS OF PLASMA OPIOID ACTIVITY IN HUMAN DIABETICS
    AWOKE, S
    VOYLES, NR
    BHATHENA, SJ
    TANENBERG, RJ
    RECANT, L
    [J]. LIFE SCIENCES, 1984, 34 (21) : 1999 - 2006
  • [6] BERGQVIST N, 1954, Acta Endocrinol Suppl (Copenh), V19, P1
  • [7] Bogacka I, 2002, J PHYSIOL PHARMACOL, V53, P439
  • [8] BRATUSCHMARRAIN P, 1980, ENDOKRINOLOGIE, V75, P235
  • [9] MENARCHE, CYCLING AND FERTILITY IN DIABETIC WOMEN
    BURKART, W
    FISCHERGUNTENHONER, E
    STANDL, E
    SCHNEIDER, HPG
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1989, 49 (02) : 149 - 154
  • [10] OPIATE BLOCKADE ENHANCES HYPOGLYCEMIC COUNTERREGULATION IN NORMAL AND INSULIN-DEPENDENT DIABETIC SUBJECTS
    CAPRIO, S
    GERETY, G
    TAMBORLANE, WV
    JONES, T
    DIAMOND, M
    JACOB, R
    SHERWIN, RS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (06): : E852 - E858